Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.15 -0.12 (-0.47%)
Official Closing Price Updated: 7:00 PM EST, Dec 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
A Tale Told Through a Bird’s Eyes: Jessica Mann’s Uplift Reimagines How We See the Natural World
Via AB Newswire
Topics Bonds
News headline image
Most active S&P500 stocks in Tuesday's session ↗
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Via Investor Brand Network
Topics Government
News headline image
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
From BioMedWire
Via GlobeNewswire
News headline image
How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗
Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam. 
Via Investor's Business Daily
News headline image
2 Top Dividend Stocks to Buy Now and Hold For a Decade ↗
These healthcare leaders can make you money while you sleep. 
Via The Motley Fool
Topics Artificial Intelligence Cannabis Intellectual Property
News headline image
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
News headline image
Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across... 
Via TokenRing AI
Topics Artificial Intelligence Economy Emissions
News headline image
S&P 500 Kicks Off December in the Red as Markets Rediscover Gravity: A Deep Dive into the Economic Headwinds
New York, NY – December 1, 2025 – The S&P 500 has begun December 2025 with a notable decline, signaling a profound shift in market sentiment as investors grapple with a confluence of challenging... 
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
News headline image
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗
Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. 
Via Investor's Business Daily
Topics Death
News headline image
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
From Pfizer Inc.
Via Business Wire
News headline image
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a... 
Via Newsfile
Topics Artificial Intelligence
News headline image
1 Oversold Stock Primed to Rebound and 2 We Find Risky
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
Topics Supply Chain
News headline image
1 Profitable Stock on Our Buy List and 2 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
2 Undervalued, High-Quality Companies to Buy Now and Hold Forever ↗
If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive. 
Via The Motley Fool
Topics Intellectual Property
News headline image
This 7% Yielder Could Be a Top AI Play ↗
One drug developer could be on the cusp of AI-powered glory. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio ↗
If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners. 
Via The Motley Fool
News headline image
These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗
If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio. 
Via The Motley Fool
Topics Energy Intellectual Property
News headline image
3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗
There are plenty of potential winners outside the world of AI. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Novo Nordisk Stock Just Hit a 4-Year Low ↗
Novo Nordisk's drug trial failure is the latest in a series of 2025 woes for the company. 
Via The Motley Fool
News headline image
Friday's session: most active stock in the S&P500 index ↗
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market. 
Via Chartmill
News headline image
8 Dividend Stocks Every Investor Should Consider ↗
From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor. 
Via The Motley Fool
News headline image
Is Pfizer Stock Underperforming the Dow?
While Pfizer has lagged behind the broader Dow Jones Industrial Average, Wall Street remains optimistic about the stock. 
Via Barchart.com
Topics Intellectual Property Stocks
News headline image
Roivant (ROIV) Q2 2026 Earnings Call Transcript ↗
Roivant (ROIV) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years ↗
These top dividend stocks could intrigue a wide range of investors. 
Via The Motley Fool
Topics Intellectual Property
News headline image
JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗
JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season. 
Via Stocktwits
Topics Economy Government
News headline image
Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings ↗
Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France. 
Via Benzinga
News headline image
Merck & Co. Stock: Is MRK Outperforming the Healthcare Sector?
Merck has outperformed the healthcare sector over the past three months. Moreover, Wall Street analysts are moderately optimistic about its prospects. 
Via Barchart.com
Topics ETFs
News headline image
Did Pfizer Just Say "Checkmate" to Novo Nordisk? ↗
The weight loss drug market may approach almost $100 billion by the end of the decade. 
Via The Motley Fool
News headline image
The Data Vacuum: How Delayed Economic Reports Are Clouding Market Stability and Investor Confidence
The financial markets are currently navigating a turbulent sea of uncertainty, grappling with the profound implications of significantly delayed economic reports. As of November 25, 2025, the... 
Via MarketMinute
Topics Bonds Credit Cards Economy
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.